This product has not been evaluated by SAHPRA. For information purposes only — not intended to diagnose, treat, cure or prevent any disease.
Mind & MoodResearch vialanxietymoodgabanon-sedatingresearch
Selank
Tuftsin analogue for anxiety without sedation
R 585
30mg vial
Anxiolytic comparable to medazepamZozulia 2008 in 62 patients with GAD or neurasthenia: intranasal Selank matched oral medazepam on anxiety reduction.
Antiasthenic and mildly stimulatingUnlike benzodiazepines, produced antiasthenic and mild psychostimulant effects rather than sedation.
GABAergic without benzo toleranceCompetes for >50% of [3H]diazepam binding sites on rat brain membranes — supports GABAergic action without classic benzodiazepine tolerance or withdrawal.
Normalises enkephalin half-lifeCorrelated with normalised leu-enkephalin half-life in clinical work.
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics in Moscow as a stabilised analogue of the immunomodulatory peptide tuftsin. It is registered as an anxiolytic in Russia. Proposed mechanisms include allosteric modulation of GABA-A receptors and modulation of brain enkephalin levels.
More in Mind & Mood
You might also like
Mind & MoodR 715
5mg vial
DSIP
Delta sleep-inducing peptide — a nonapeptide isolated in 1977 from the cerebral venous blood of rabbits in induced slow-wave sleep. Crosses the blood-brain barrier; receptor target has never been definitively identified.
View details →
Mind & MoodR 585
30mg vial
Semax
Synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), an analogue of ACTH(4-10) developed in 1980s Moscow. On Russia's List of Vital and Essential Drugs, prescribed there for stroke recovery and cognitive complaints.
View details →
Regulatory
This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.